Skip to content
PortiVixBy VirtuNx
The PortiVix platform

One operating model for pharma portfolio decisions and project execution.

PortiVix connects the commercial view of molecules and portfolios with the execution view of projects, workstreams, tasks, resources, materials, risks, issues, reports, and audit evidence.

The command centre

Portfolio health and pipeline value, in one live view.

Leadership sees eNPV, at-risk molecules, and phase movement without waiting for a status pack - the same governed record that delivery teams work in every day.

portfolio · command centrelive
Portfolio eNPV
$2.4B
At-risk
3
On-track
82%
pipeline · by phase6 molecules
Discovery
VX-118
$70m
Ph I
VX-204
$180m
Ph II
VX-330
$412m
VX-355
$260m
Ph III
VX-441
$690m
Filed
VX-509
$910m
Two connected hierarchies

Leadership thinks in portfolios. Delivery teams work in projects. PortiVix connects both.

Pharma organisations need both views - without forcing teams into one flat project structure. Leadership thinks in portfolios, molecules, phase gates, risk, and value. Delivery teams work through projects, workstreams, tasks, dependencies, resources, and approvals.

Commercial / molecule hierarchy

  1. TenantOrganisation

    Your isolated, configured environment.

  2. PortfolioPipeline view

    Leadership view of pipeline health and value.

  3. ProgrammeGrouped assets

    Related molecules by indication, stage, or objective.

  4. MoleculeAsset record

    Commercial, patent, phase, risk, financial, and decision history.

  5. Phase / TaskProgress

    Planned, estimated, actual, and LBE dates.

Execution hierarchy

  1. TenantOrganisation

    Same governed boundary as the commercial view.

  2. PortfolioDelivery view

    Portfolio-level Gantt across projects.

  3. ProjectExecution plan

    Structured, template-driven, and governed.

  4. WorkstreamDepartment delivery

    R&D, ADL, RA, QA, manufacturing, supply, commercial.

  5. MilestoneGate

    Critical path indicators and roll-up.

  6. TaskOwned work

    Approvals, comments, @mentions, documents.

  7. SubTaskBreakdown

    Detailed decomposition of a task.

  8. ActivityAtomic step

    Where progress is captured first.

Project execution

Milestone to activity, with critical path, risks, and issues.

Delivery teams work the same governed record leadership sees - a structured plan of milestones, tasks, and subtasks, with dependencies, critical path, a project risk register, and an issue tracker.

project · plan & critical pathMilestone → Task → SubTask
Q1Q2Q3Q4
M1 · Ph II readiness
Formulation development
Prototype trials
Analytical method (ADL)
Stability setup
R
M2 · Exhibit batch
Scale-up / exhibit batch
R
Regulatory dossier (ANDA)
I
M3 · Submission
Critical pathTask / subtaskMilestoneRiskIssue
Governance roll-up

Task-level progress becomes portfolio visibility.

Progress captured at the activity level rolls up through workstreams and projects into programme and portfolio views - and leadership decisions flow back down into governed execution.

01Task updateowner marks progress
02Workstream progressdepartment roll-up
03Project healthmilestones & critical path
04Programme riskcross-molecule view
05Portfolio dashboardleadership visibility
Inside the model

Five levels, one connected record.

Level 01

Portfolio - executive command across programmes, molecules, projects, risk, and value.

The leadership view of pipeline health: active molecules, programmes, projects, milestones, risks, issues, financial metrics, and resource pressure - without waiting for a manually assembled pack.

  • Portfolio-level Gantt across projects
  • Command Centre with molecule, project, risk, and financial indicators
  • Configurable discovery and access modes
  • Portfolio trends and historical performance
  • Named owner accountability and audit trail
Level 02

Programme - group assets around the decisions leadership needs to make.

Programmes group related molecules by indication, lifecycle stage, commercial objective, or therapeutic area - surfacing what is moving, blocked, or needs escalation before it becomes a portfolio surprise.

  • Programme manager ownership
  • Status visibility across linked molecules and projects
  • PMO governance reporting
  • Cross-programme milestone and risk tracking
Level 03

Molecule - every asset, every assumption, every decision record.

The single source of truth for the asset: pharma classification, commercial assumptions, patent and regulatory fields, phase gates, PTRS and risk scores, NPV/eNPV, materials, documents, snapshots, and decision commentary.

  • Manual creation or FDA-assisted Portfolio Builder import
  • Commercial metrics: market size, revenue at launch, peak revenue, kill threshold
  • Patent expiry tracking: DS, DP, and AoP
  • Phase management: planned, estimated, actual, and LBE dates
  • Snapshots and baselines for before-and-after comparisons
Level 04

Project - governed execution from milestone to activity.

Structured plans with milestones, tasks, subtasks, activities, dependencies, critical path indicators, approvals, comments, documents, risks, issues, and template-driven setup.

  • Four-level plan: Milestone -> Task -> SubTask -> Activity
  • Dependencies: FS, SS, FF, and SF with lag days
  • Interactive Gantt and portfolio-level Gantt
  • Template lock mechanics for governed project plans
  • Approval queue, comments, @mentions, documents, activity feed
Level 05

Workstream - cross-functional delivery, visible by department.

Workstreams coordinate R&D, ADL, formulation, regulatory, QA/QC, manufacturing, supply chain, and commercial functions - each with department ownership, milestones, tasks, progress, and escalation paths.

  • Department-linked workstreams
  • Named workstream owners
  • Reorderable milestones and critical path indicators
  • Progress roll-up into project and portfolio views
  • Workstream Progress report

See the operating model mapped to your pipeline.

We do not start with a generic demo. We map your portfolio, molecule, project, approval, reporting, and governance workflows first - then show how PortiVix would work for your organisation.